CAS: 2746-25-0; 1-(Bromomethyl)-4-Methoxybenzene

该化合物是一种多用途有机化合物,通常用作合成化学中的烷基或保护剂,其主要优点包括:由于电子捐赠的甲氧基混合物组提高了苯基溴的核生殖替代效率,因此具有高度的再活性;该化合物在peptide合成和制药中间体中特别有用,需要选择性地保护氢氧或苯胺组;在二氯甲烷和THF等常见有机溶剂中表现出良好的溶解性,便于直接的反应处理;由于对水分和光的敏感性,建议在惰性条件下谨慎储存;该化合物的稳定性和可预测的再活性使它成为复杂的有机转化的可靠选择.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号105-13-5 对甲氧基苄醇 | CAS号631-61-8 乙酸铵 | CAS号123-11-5 4-甲氧基苯甲醛; 对甲氧基苯... | CAS号104-93-8 4-甲基苯甲醚(MSO) | CAS号18494-82-1 2-[(4-methoxyph... | CAS号14629-56-2 (4-Methoxybenzy... | CAS号92565-78-1 4-ch3°C6h4ch2omom | CAS号106-44-5 对甲酚 | CAS号824-94-2 4-甲氧基苄氯 | CAS号112089-06-2 9-[(4-methoxyph... | CAS号112088-77-4 6-chloro-9-(4-m... | CAS号112088-76-3 6-chloro-9-[(4-... | CAS号105192-33-4 6-[(4-methoxyph... | CAS号102831-36-7 6-(4-methoxyphe... | CAS号103-87-7 alpha-dimethyla... | CAS号3168-59-0 2-甲基-5-甲氧基苯甲酸 | CAS号3462-97-3 (4-甲氧基苄基)三苯基氯化膦 | CAS号3694-57-3 4-甲氧基苄基异硫氰酸酯

合成工艺路线路线简述

    对甲苯甲醚置于n-溴代丁二酰亚胺(Nbs)体系中,用 四氯化碳 用作溶剂,化学反应 2.0H,反应生成4-甲氧基溴苄
    参考文献:无金属条件下甲基芳烃一锅法转化为芳香醛
    标题:无金属条件下甲基芳烃一锅法转化为芳香醛
    摘要:在通过用 N-甲基吗啉 N-氧化物处理将苄基溴转化为相应的芳香醛的研究的基础上,在 Aibn 的存在下,在回流的乙腈中用 Dbdmh 或用 Nbs 处理各种甲基芳烃ccl4置于30 oc 下用钨灯照射(方法 B),然后用 N-甲基吗啉 N-氧化物处理以提供高产率的芳香醛.这些方法可用于在无毒性较小的试剂和过渡金属的条件下将甲基芳烃一锅法转化为芳香醛.
    Doi:10.1002/ejoc.201402015

    海关参考信息

    专利信息


    专利号:WO-2021014395-A1
    优先权日:2019-07-24
    标题:Process for the synthesis of deuterated capsaicin, capsaicinoids and synthetic capsaicin analogs
    发明人:ORUGANTI SRINIVAS; AMRUTAPU SRAVANTH KUMAR; SAMPATH MAGESH; SEN SAIKAT
    权利人:DR REDDY’S INST OF LIFE SCIENCES
    摘要:The present application provides novel processes for the synthesis of deuterated intermediates of capsaicinoids, particularly II, III, IV and V of capsaicinoids, relating to pharmaceutical applications. The invention also provides novel intermediates of compounds of formula IX, XIV, XV, XVI, XVII, XVIII, XX and XXI utilized in the process of making deuterated capsaicin II, III, IV and V.

    专利号:US-2004018598-A1
    优先权日:2000-05-30
    标题 :Bio-intermediates for use in the chemical synthesis of polyketides
    发明人:SANTI DANIEL; ASHLEY GARY; MYLES DAVID C
    摘要:The present invention relates to compounds made by a subset of modules from one or more polyketide synthase (“PKSâ€?) genes that are used as starting material in the chemical synthesis of novel molecules, particularly naturally occurring polyketides or derivatives thereof. The biologically derived intermediates (“bio-intermediatesâ€?) generally represent particularly difficult compounds to synthesize using traditional chemical approaches due to one or more stereocenters. In one aspect of the invention, an intermediate in the synthesis of epothilone is provided that feeds into the synthetic protocol of Danishefsky and co-workers. In another aspect of the invention, intermediates in the synthesis of discodermolide are provided that feed into the synthetic protocol of Smith and co-workers. By taking advantage of the inherent stereochemical specificity of biological processes, the syntheses of key intermediates and thus the overall syntheses of compounds like epothilone and discodermolide are greaty simplified.

    专利号:US-9556140-B2
    优先权日:2013-01-26
    标 题 :Approach for synthesis of catechins
    发明人:DUGAR SUNDEEP; MAHAJAN DINESH; RAI KUMAR SANTOSH; TRIPATHI VINAYAK; PATIL ISHWAR RAKESH
    权利人:SPHAERA PHARMA PRIVATE LTD
    摘要:A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+ and/or −) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-protected quercetin obtained from step (i); (iii) optionally deprotecting the compound of step (ii); (iv) reducing the compound obtained from step (ii) or step (iii) in the presence of a chiral/achiral reducing agent to obtain a chiral intermediate; (v) deprotecting and/or hydrogenation of the chiral intermediate obtained from step (iv) to obtain (−)-epicatechin; (vi) optionally simultaneously deprotecting and by drogenation of the compound obtained from step (ii) to obtain racemic epicatechin.

    专利号:US-6455680-B1
    优先权日:2000-12-21
    标 题 :Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
    发明人:LUKIN KIRILL A
    权利人:ABBOTT LAB
    摘要:An efficient deoximation technique for use in synthesis of erythromycin derivatives, involving aryl thioimine intermediates is disclosed. The aryl thioimine intermediates can be utilized in a method for protecting a ketone of a ketone-containing erythromycin derivative as a thioimine; a method for deoximating an oxime-containing erythromycin derivative, or a method for preparing a 6-O-alkyl erythromycin derivative. Presently preferred erythromycin derivatives have a C-9 oxime or a C-9 ketone.

    专利号:WO-2020255049-A1
    优先权日:2019-06-20
    标题:Process for the preparation and identification of deuterated eugenol
    发明人:ORUGANTI SRINIVAS; AMRUTAPU SRAVANTH KUMAR; SAMPATH MAGESH; SEN SAIKAT
    权利人:DR REDDY’S INST OF LIFE SCIENCES
    摘要:The present invention provides a novel, simple, unique and viable processes for the synthesis of deuterium incorporated eugenols, such as deuterated eugenol (II), regioisomeric deuterated eugenol (III), and deuterated variant of methyl eugenol (V).

    专利号:US-8987430-B2
    优先权日:2009-10-30
    标 题:Efficient and scalable process for the manufacture of fondaparinux sodium
    发明人:PATEL PAYAL PARTH; MA CHUN; OHRR KEVIN K; NADJI SOURENA
    权利人:PATEL PAYAL PARTH; MA CHUN; OHRR KEVIN K; NADJI SOURENA; RELIABLE BIOPHARMACEUTICAL CORP
    摘要:The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.
    江苏贵仁医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.guirenchem.com
    电话:0519-83489086;13601507568👤
    📞 江苏贵仁医药有限公司⚠️参考联系方式

    电话: 0519-83489086;13601507568
    邮件:sales@guirenchem.com
    网址: http://www.guirenchem.com
    地址:江苏省常州市芮城县风陵渡开发区振兴北街北侧
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    江苏省常州市芮城县风陵渡开发区振兴北街北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    山东西亚化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xiyashiji.com
    企业联系电话:400-990-3999👤
    📞山东西亚化学有限公司 ⚠️参考联系方式
    联系人:徐雪
    电话:400-990-3999
    手机:13395398332
    传真:0539-6365991
    邮箱:3007715518@qq.com
    通信地址: 临沭经济开发区化工园区(厂址)
    邮编: 276000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:临沭经济开发区化工园区(厂址)
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Griesbeck, A. G.; Soldevilla, A., Science of Synthesis, (2008) 43, 376.
    摘要:Aitken, R. A., Science of Synthesis Knowledge Updates, (2022) 2, 29.
    摘要:Irudayanathan, F. M.; Lee, S., Science of Synthesis Knowledge Updates, (2019) 2, 15.
    摘要:Götzinger, A. C.; Müller, T. J. J., Science of Synthesis Knowledge Updates, (2017) 3, 163.
    摘要:Gleason, J. L.; Tiong, E. A., Science of Synthesis Knowledge Updates, (2010) 4, 293.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知